Page | |
EDITORIALS |
89 | Systematic mediastinal staging in non-small cell lung cancer: Filling in the guideline evidence gap
|
92 | Intergenerational trauma and long-term lung dysfunction: Early life exposures and pulmonary function in Indigenous Australian adults
|
INVITED REVIEW SERIES |
The Future of Asthma |
94 | Mild asthma: Conundrums, complexities and the need to customize care
|
POSITION PAPER |
105 | Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
John A Mackintosh, Gregory Keir, Lauren K Troy, Anne E Holland, Christopher Grainge, Daniel C Chambers, Debra Sandford, Helen E Jo, Ian Glaspole, Margaret Wilsher, Nicole S L Goh, Paul N Reynolds, Sally Chapman, Steven E Mutsaers, Sally de Boer, Susanne Webster, Yuben Moodley, Tamera J Corte
10.1111/resp.14656 |
ORIGINAL ARTICLES |
Interstitial Lung Disease |
136 | Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias
Takahito Suzuki, Masato Karayama, Yoichiro Aoshima, Kazutaka Mori, Nobuko Yoshizawa, Shintaro Ichikawa, Shinpei Kato, Koshi Yokomura, Masato Kono, Dai Hashimoto, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Satoshi Goshima, Naoki Inui, Takafumi Suda
10.1111/resp.14621
The lung immune prognostic index (LIPI), composed of white blood cell and neutrophil counts, and lactate dehydrogenase levels, is predictive for the prognosis of patients with IPF. The LIPI, a simple index readily calculated from a routine blood test, can provide useful information for the management of patients with IPF. |
146 | Clinical features and outcomes of small airway disease in ANCA-associated vasculitis
Peining Zhou, Li Gao, Zhiying Li, Chengli Que, Haichao Li, Jing Ma, Guangfa Wang
10.1111/resp.14611
Small airway disease (SAD) is a unique manifestation of ANCA-associated vasculitis (AAV), which is associated with prognosis and infection, and has a better response to immunosuppressors. Extra attention should be paid to the imaging features of AAV patients to better balance antibiotics and immunosuppressors, which are conducive to long-term outcomes. |
Lung Cancer |
158 | EBUS-TBNA for mediastinal staging of centrally located T1N0M0 non-small cell lung cancer clinically staged with PET/CT
Pere Serra Mitjà, Bruno García-Cabo, Ignasi Garcia-Olivé, Joaquim Radua, Ramón Rami-Porta, Lluís Esteban, Bienvenido Barreiro, Sergi Call, Carmen Centeno, Felipe Andreo, Carme Obiols, Juan Manuel Ochoa, Mireia Martínez-Palau, Nina Reig, Mireia Serra, José Sanz-Santos
10.1111/resp.14613
The diagnostic performance of EBUS-TBNA for mediastinal staging of centrally located T1N0M0 NSCLC has never been reported. Our study shows that EBUS-TBNA presents a good diagnostic performance, even in patients with low prevalence of N2 disease. Its indication should be considered in the management of even these early lung cancers.
See related editorial |
Lung Function |
166 | Association between perinatal and early life exposures and lung function in Australian Indigenous young adults: The Aboriginal Birth Cohort study
Vidya Navaratnam, Douglas L Forrester, Anne B Chang, Shyamali C Dharmage, Gurmeet R Singh
10.1111/resp.14639
Our study provides first estimates on the proportion of Indigenous Australians with abnormal spirometry and FEV1 below the population mean. We also demonstrate maternal and early childhood factors associated with impaired lung function. The findings contribute to the evidence in support of optimization of respiratory health in early childhood.
See related editorial |
Pleural Disease |
176 |
Topical antibiotics prophylaxis for infections of indwelling pleural/peritoneal catheters (TAP-IPC): A pilot study
Estee P M Lau, Sam Faber, Chloe Charlesworth, Sue Morey, Sona Vekaria, Pierre Filion, Aron Chakera, Y C Gary Lee
10.1111/resp.14595
Indwelling pleural catheter-related infections remain a major concern for which no long-term preventative strategies exist. Topical antibiotics prophylaxis for infections of indwelling pleural/peritoneal catheters (TAP-IPC) is a pilot study applying regular topical mupirocin as prophylaxis for indwelling pleural/peritoneal catheters (n = 50). The treatment regimen was feasible and well-tolerated, and its efficacy will be tested in a randomized trial. |
FORUM AND DEBATE |
Personal Reflections |
183 | Education, education, education!
|
185 | The raw stuff we cannot do without
|
Letter from Asia-Pacific and Beyond |
187 | Letter from Australia
|